Skip to main content

Table 1 Socio-demographic, clinical, and hospital characteristics of the 3658 patients

From: Intensive end-of-life care in acute leukemia from a French national hospital database study (2017–2018)

Socio-demographic data

N (%)

Age at death (years)

  < 60

417 (11.4)

 [60–70]

623 (17.0)

 [70–80]

1150 (31.4)

  ≥ 80

1468 (40.1)

Sex

 Male

2037 (55.7)

 Female

1621 (44.3)

Year of death

 2017

1813 (49. 6)

 2018

1845 (50.4)

Social area living

 Socially advantaged

1608 (44.0)

 Socially disadvantaged

2001 (54.7)

 Missing data

49 (1.3)

Clinical Data

N (%)

Type of leukemia

 Acute myeloid leukemia

3426 (93.7)

 Acute promyelocytic leukemia

20 (0.6)

 Acute myelomonocytic leukemia

170 (4.7)

 AML with 11q23

19 (0.5)

 AML with dysplasia of several cell lines

161 (4.4)

 Acute monoblastic/monocytic leukemia

123 (3.4)

 Acute pan myelosis with myelofibrosis

72 (2.0)

 Megakaryocyte leukemia

22 (0.6)

 Acute erythroid leukemia

31 (0.9)

 Acute lymphoid leukemia

231 (6.3)

Months between diagnosis and death

  ≤ 3

703 (19.2)

  [3–12]

806 (22.0)

  [12–36]

1084 (29.6)

  > 36

1065 (29.1)

Allogeneic stem cell transplantation

 No

3394 (92.8)

 Yes

264 (7.2)

Charlson score (co-morbidities) a

 0

1459 (39.9)

 1–2

1411 (38.6)

  ≥ 3

788 (21.5)

Last hospitalization stay

N (%)

Type of hospital c

 Non-specialized hospital

2245 (61.4)

 Specialized hospital

1413 (38.6)

Death in an intensive care structure

495 (13.5)

Palliative care structure in the last 3 days of life b

745 (20,4)

Time in a palliative care structure before death

  ≤ 1 month

2545 (69.6)

  > 1 month

1113 (30.4)

Travel time from patients’ home (minutes)

  ≤ 10

1047 (28.6)

  [10–30]

1071 (29.3)

  [30–60]

652 (17.8)

  > 60

945 (21.8)

Length of stay (days)

  ≤ 15

1382 (37.8)

  [15–30]

1361 (37.2)

  > 30

929 (25.0)

  1. a Charlson modified score (excluding malignancies/metastasis)
  2. b Intensive care structure includes intensive care unit, ressuscitation unit, emergency unit
  3. c Specialized centers include cancer units of an university hospital and units of a cancer hospital, non-specialized centers include all the other cases